Metabolism guided optimization of peptidomimetics as non-covalent proteasome inhibitors for cancer treatment.
Cao Y, Tu Y, Fu L, Yu Q, Gao L, Zhang M, Zeng L, Zhang C, Shao J, Zhu H, Zhou Y, Li J, Zhang J.
Cao Y, et al. Among authors: zhang m, zhang c, zhang j.
Eur J Med Chem. 2022 Apr 5;233:114211. doi: 10.1016/j.ejmech.2022.114211. Epub 2022 Feb 21.
Eur J Med Chem. 2022.
PMID: 35218994